Allergic Rhinitis Drug Market By Treatment Type (Antihistamines, Immunotherapy {Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)}, Corticosteroids, Decongestants, Others), By Disease Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Drug (Prescription, OTC), By Route of Administration (Oral, Nasal, Intraocular, Intravenous), By Distribution channel (Hospital pharmacies, Retail pharmacies, Online channels) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Report Coverage:

By Treatment Type

• Antihistamines
• Immunotherapy
  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
• Corticosteroids
• Decongestants
• Others

By Disease Type

• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis

By Drug

• Prescription
• OTC

By Route of Administration

• Oral
• Nasal
• Intraocular
• Intravenous

By Distribution channel

• Hospital pharmacies
• Retail pharmacies
• Online channels

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Adamis Pharmaceuticals
• Alcon
• AstraZeneca
• Bayer AG
• Boehringer Ingelheim
• Dr Reddy's Laboratories
• GlaxoSmithKline PLC
• Innovus Pharmaceuticals, Inc.
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan NV
• Sanofi S.A.
• Sun Pharmaceuticals
• Teva Pharmaceutical Industries Ltd
• Unichem Laboratories